Dongbang Medical Debuts on KOSDAQ: A New Era for Traditional and Cosmetic Medical Devices

Dongbang Medical, a leader in traditional and cosmetic medical devices, has officially begun trading on KOSDAQ. This could mark a pivotal point for the company and the broader medical device sector.

Key Highlights of Dongbang Medical’s KOSDAQ Debut

• Public Offering Success: The company set its public offering price at 10,500 KRW. The initial public offering (IPO) saw substantial interest, achieving a subscription rate of 106.3 to 1 from general investors.
• Investor Interest: Institutional investor interest was remarkable with a demand forecast competition rate of 910.14 to 1, indicating strong confidence in the company’s potential.

Funding Allocation and Strategy

Dongbang Medical plans to use the funds from the IPO strategically:

• Expanding Global Reach: Invest heavily in expanding into the U.S., European, and Middle Eastern markets.
• Innovation in Product Development: Focus on developing new filler products, including PGA, PN, and PLA fillers, to complement existing HA fillers.
• Leadership in Traditional Medical Devices: Continue to dominate the traditional medical device market, holding a 60-70% market share in domestic needle and cupping device markets.

Performance and Future Prospects

Dongbang Medical demonstrates resilient growth:

• The company combines technical expertise in traditional devices with advancements in cosmetic devices.
• It targets a significant revenue milestone of 2.5 trillion KRW by 2028, aiming for a 30% operating profit margin.

Dongbang Medical’s strategy is built on:

• Expanding market share in beauty devices, with plans to increase revenue share to 81% by 2028.
• Entering large global markets in cosmetic surgery, particularly in countries like the U.S. and Brazil.

Company Leadership and Vision

CEO Kim Geun-Sik emphasizes the balance between stable profitability from traditional devices and aggressive market expansion for cosmetic devices. The company plans to fast-track market entry in the world’s leading beauty markets using the capital raised from the IPO.

Market and Industry Context

Traditional and Cosmetic Medical Devices

Both traditional and modern cosmetic medical devices offer expansive potential:

• Traditional Devices: Serve a stable market with high domestic demand, driven by a preference for non-invasive treatments and cultural acceptance.
• Cosmetic Devices: Gain traction due to increasing demand for non-invasive aesthetic procedures. Dongbang Medical’s growth reflects a broader industry trend.

Benefits for Investors

Investing in Dongbang Medical offers:

• Potential for High Returns: Given the company’s strategic initiatives in high-growth markets.
• Portfolio Diversification: Gaining exposure to both traditional and advanced medical technology sectors.

Conclusion

Dongbang Medical’s KOSDAQ debut could lead to substantial growth opportunities, leveraging its strong market position in Korea and forward-looking strategies in the international market. For investors and stakeholders, the focus will be on how effectively the company executes its expansion and innovation plans in the highly competitive medical device sector.

Table of Contents:

1. Introduction
   • Overview of Dongbang Medical’s KOSDAQ debut
   • Significance of this launch for the company and the broader medical device market
2. Key Highlights of Dongbang Medical’s KOSDAQ Debut
   • Success of the public offering, including pricing and subscription rates
   • Institutional investor interest and confidence reflected in demand forecasts
3. Funding Allocation and Strategy
   • Plans for using IPO funds to expand into global markets
   • Focus on innovation in product development, particularly filler products
   • Commitment to leadership in the traditional medical devices sector
4. Performance and Future Prospects
   • Overview of Dongbang Medical’s growth trajectory and revenue targets
   • Strategies for expanding market share in cosmetic devices
   • Aiming for significant revenue milestones by 2028
5. Company Leadership and Vision
   • Insights from CEO Kim Geun-Sik on balancing profitability and market expansion
   • Strategic plans for entering leading beauty markets
6. Market and Industry Context
   • Analysis of traditional and cosmetic medical devices market dynamics
   • The growing demand for non-invasive treatments and aesthetic procedures
7. Benefits for Investors
   • Potential for high returns from Dongbang Medical’s strategic initiatives
   • Portfolio diversification across traditional and modern medical technology sectors
8. Conclusion
   • Summary of the implications of Dongbang Medical’s KOSDAQ listing
   • Future outlook for the company’s growth and innovation strategies in the competitive medical device landscape